Contact this trialFirst, we need to learn more about you.
Immunotherapy for Skin Cancer
Recruiting1 awardPhase 2
Pittsburgh, Pennsylvania
This trial will test if a new immunotherapy drug can help patients with a certain type of skin cancer that has not been treated before. The study will last 52 weeks and will help researchers see if the drug could improve survival for patients with this type of skin cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service